Get the Stockscreener App
21.69
0.60%
-0.1356
Progyny Inc stock is traded at $21.69, with a volume of 695.45K.
It is down -0.60% in the last 24 hours and up +24.14% over the past month.
Progyny Inc is a company engaged in specializing in fertility and family building benefits solutions. Its clients include employers across various industries. The fertility benefits solution consists of the treatment services (Smart Cycles), access to the Progyny network of high-quality fertility specialists that perform the Smart Cycle treatments and active management of the selective network of high-quality provider clinics.
See More
Previous Close:
$21.83
Open:
$21.81
24h Volume:
695.45K
Relative Volume:
0.42
Market Cap:
$1.86B
Revenue:
$1.13B
Net Income/Loss:
$62.75M
P/E Ratio:
34.44
EPS:
0.63
Net Cash Flow:
$170.92M
1W Performance:
-6.34%
1M Performance:
+24.14%
6M Performance:
+4.08%
1Y Performance:
-45.46%
1-Day Range:
$21.56
$22.30
1-Week Range:
$21.56
$23.81
52-Week Range:
$13.39
$42.08
Progyny Inc Stock (PGNY) Company Profile
Name
Progyny Inc
Sector
Industry
Phone
212-888-3124
Address
1359 BROADWAY, NEW YORK, NY
Compare PGNY with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PGNY
Progyny Inc
|
21.70 | 1.86B | 1.13B | 62.75M | 170.92M | 0.63 |
|
VEEV
Veeva Systems Inc
|
236.47 | 38.87B | 2.66B | 665.91M | 1.08B | 4.05 |
|
SOLV
Solventum Corp
|
73.17 | 12.92B | 8.26B | 66.00M | 1.17B | 0.3682 |
|
DOCS
Doximity Inc
|
78.61 | 10.88B | 516.85M | 174.11M | 217.38M | 0.87 |
|
TEM
Tempus Ai Inc
|
67.90 | 10.23B | 640.44M | -743.28M | -206.93M | -11.29 |
|
HQY
Healthequity Inc
|
111.69 | 9.71B | 1.15B | 96.70M | -161.99M | 1.09 |
Progyny Inc Stock (PGNY) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-02-24 | Downgrade | JP Morgan | Overweight → Neutral |
| Nov-13-24 | Downgrade | Truist | Buy → Hold |
| Sep-19-24 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| Aug-07-24 | Downgrade | BTIG Research | Buy → Neutral |
| Aug-07-24 | Downgrade | Canaccord Genuity | Buy → Hold |
| Aug-07-24 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Jul-16-24 | Initiated | JMP Securities | Mkt Outperform |
| May-10-24 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Feb-26-24 | Initiated | Leerink Partners | Outperform |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Sep-27-23 | Initiated | Canaccord Genuity | Buy |
| May-22-23 | Initiated | BTIG Research | Buy |
| Apr-21-23 | Initiated | Cantor Fitzgerald | Overweight |
| Jan-05-23 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Overweight |
| Sep-07-22 | Initiated | Truist | Buy |
| Dec-02-21 | Initiated | Jefferies | Buy |
| Nov-22-21 | Downgrade | Citigroup | Buy → Neutral |
| Sep-30-21 | Initiated | Berenberg | Buy |
| Aug-12-21 | Initiated | Barclays | Overweight |
| Jun-02-21 | Downgrade | Guggenheim | Buy → Neutral |
| Apr-29-21 | Resumed | JP Morgan | Overweight |
| Mar-10-21 | Upgrade | BofA Securities | Neutral → Buy |
| Jul-01-20 | Initiated | SVB Leerink | Outperform |
| Jun-02-20 | Initiated | Guggenheim | Buy |
| Nov-19-19 | Initiated | Citigroup | Buy |
| Nov-19-19 | Initiated | Goldman | Buy |
| Nov-19-19 | Initiated | JP Morgan | Overweight |
| Nov-19-19 | Initiated | Piper Jaffray | Overweight |
| Nov-19-19 | Initiated | SVB Leerink | Outperform |
View All
Progyny Inc Stock (PGNY) Latest News
The Play On Progyny: Don't Chase, But Watch And Wait (NASDAQ:PGNY) - Seeking Alpha
Vanderbilt University Buys New Shares in Progyny, Inc. (NASDAQ:PGNY) - MarketBeat
22,001 Shares in Progyny, Inc. (NASDAQ:PGNY) Bought by Guidance Capital Inc. - MarketBeat
Truist Securities Adjusts Progyny Price Target to $24 From $19, Maintains Hold Rating - Marketscreener.com
All You Need to Know About Progyny (PGNY) Rating Upgrade to Buy - MSN
SG Americas Securities LLC Has $597,000 Stake in Progyny, Inc. (NASDAQ:PGNY) - MarketBeat
(PGNY) Proactive Strategies - Stock Traders Daily
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Progyny, Inc. (PGNY) And Encourages Shareholders to Reach Out - ACCESS Newswire
Progyny, Inc. (NASDAQ:PGNY) Receives $25.50 Consensus Price Target from Brokerages - MarketBeat
Pacer Advisors Inc. Boosts Stock Holdings in Progyny, Inc. (NASDAQ:PGNY) - MarketBeat
Progyny (NASDAQ:PGNY) Price Target Raised to $23.00 at JPMorgan Chase & Co. - MarketBeat
Will Progyny (PGNY) Beat Estimates Again in Its Next Earnings Report? - MSN
BenefitBump acquired by Progyny - The Business Journals
Progyny expands family support with BenefitBump acquisition - MSN
Progyny announces acquisition of BenefitBump, terms not disclosed - Yahoo Finance
St. Louis family benefits startup acquired by public company - The Business Journals
Progyny Acquires Parental Leave Benefits Manager BenefitBump; Shares Rise -January 28, 2025 at 10:25 am EST - Marketscreener.com
Progyny expands family support with BenefitBump acquisition By Investing.com - Investing.com Canada
Progyny, Inc. Enhances Suite of Services with Acquisition of BenefitBump - GlobeNewswire
Game-Changing Parental Benefits Deal: Progyny Just Solved Working Parents' Biggest Challenge - StockTitan
Fort Washington Investment Advisors Inc. OH Purchases 695,740 Shares of Progyny, Inc. (NASDAQ:PGNY) - MarketBeat
Witness A Substantial Acquisition As DEBRA MORRIS Acquires Progyny Stock Options Worth $37K - Benzinga
Clear Harbor Asset Management LLC Purchases Shares of 57,335 Progyny, Inc. (NASDAQ:PGNY) - MarketBeat
(PGNY) On The My Stocks Page - Stock Traders Daily
Progyny shares surge 54% after November Fair Value signal flagged undervaluation - MSN
PGNY Stockholders: Robbins LLP is Investigating the Officers and Directors of Progyny, Inc. to Determine if They Breached Fiduciary Duties Owed to Shareholders - Kilgore News Herald
Progyny adds healthcare veteran Debra Morris to board By Investing.com - Investing.com Australia
Progyny appoints Debra Morris as new board member By Investing.com - Investing.com Australia
IVF treatment demand drops after Alabama ruling, and Progyny’s stock tumbles - MSN
Progyny appoints Debra Morris as new board member - MSN
Progyny adds healthcare veteran Debra Morris to board - MSN
Progyny, Inc Appoints Debra Morris to Its Board of Directors and Compensation Committee - Marketscreener.com
Progyny Strengthens Leadership with New Director Appointment - TipRanks
Progyny Appoints Debra Morris to Board of Directors - citybiz
Progyny Appoints Healthcare Veteran Debra Morris to Board of Directors - GlobeNewswire
Progyny Strengthens Board with Healthcare Veteran Debra Morris, AccessHope President Joins - StockTitan
Rep. Josh Gottheimer Sells Progyny, Inc. (NASDAQ:PGNY) Shares - MarketBeat
Progyny: The Growth Story Remains Intact (NASDAQ:PGNY) - Seeking Alpha
Progyny FY2024 EPS Estimate Increased by Leerink Partnrs - MarketBeat
Progyny sees Q4 results slightly above guidance ranges provided in November - MSN
Leibman Financial Services Inc. Grows Stock Position in Progyny, Inc. (NASDAQ:PGNY) - MarketBeat
Progyny Inc Stock (PGNY) Financials Data
Revenue
Net Income
Cash Flow
EPS
Progyny Inc Stock (PGNY) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Anevski Peter | CHIEF EXECUTIVE OFFICER |
Dec 23 '24 |
Buy |
14.48 |
209,500 |
3,034,084 |
441,463 |
8.77%
0.88%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):